# US 2001/0034435 A1 · Process and equipment for plasmid purification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0034435 A1
- Document ID: US20010034435A1
- Status: Published application
- Kind: A1
- Application number: 09/774,284
- Filed: 2001-01-29
- Published: 2001-10-25
- Earliest claimed: 1996-07-19
- Assignees: Valentis, Inc.
- Inventors: Samuel Nochumson; Ross Durland; Audrey Yu-Speight; John Welp; Kuoewi Wu; Rexford Hayes
- Web page: https://patentgrep.com/patent/US20010034435A1

## CPC

- B01D 15/327: {with hydrophobic interaction}
- B01D 15/363: {Anion-exchange}
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12N 15/101: {by chromatography, e.g. electrophoresis, ion-exchange, reverse phase}
- C12N 15/1017: {by filtration, e.g. using filters, frits, membranes}
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A scalable alkaline lysis process, including procedures and devices for the isolation of large quantities (grams and kilograms) of plasmid DNA from recombinant E. coli cells. Effective, controllable, and economical operation, and consistent low level of host chromosomal DNA in the final plasmid product. Involves a series of new unit operations and devices for cell resuspension, cell lysis, and neutralization.

## Claims

### Claim 1

A process for isolating plasmid DNA comprising the steps of:
(a) lysing cells containing said plasmid DNA with a lysis agent, thereby forming a lysate;
(b) treating said lysate with a high salt agent, thereby forming a treated solution; and
(c) purifying said treated solution to provide isolated plasmid DNA.

### Claim 2 (depends on 1)

The process of claim 1, wherein said plasmid DNA is a mixture of supercoiled plasmid DNA, nicked circle plasmid DNA, and linearized plasmid DNA.

### Claim 3 (depends on 1)

The process of claim 1, wherein said process does not involve the use of RNase.

### Claim 4 (depends on 1)

The process of claim 1, wherein said high salt agent is capable of precipitating a significant portion of any RNA molecules from said cells.

### Claim 5 (depends on 1)

The process of claim 1, wherein said high salt agent comprises one or more salts at a pH above approximately 5.5.

### Claim 6 (depends on 5)

The process of claim 5, wherein said high salt agent comprises a mixture of 1M potassium acetate and 7M ammonium acetate at a pH between 7.0 and 9.0.

### Claim 7 (depends on 6)

The process of claim 6, wherein said lysate is treated with said high salt agent for at least six hours at approximately four degrees Celsius.

### Claim 8 (depends on 1)

The process of claim 1, wherein said isolated plasmid DNA is pharmaceutical-grade plasmid DNA suitable for administration to humans.

### Claim 9 (depends on 1)

The process of claim 1, wherein at least 100 milligrams of said isolated plasmid DNA is obtained.

### Claim 10

A process for isolating plasmid DNA comprising the steps of:
(a) resuspending cells in approximately 50 mM of Tris at a pH of about 8.0 and approximately 10 mM EDTA(Na)2;
(b) lysing cells containing said plasmid DNA with a lysis agent comprising an approximately equal volume of 0.2N sodium hydroxide in 1% SDS, thereby forming a lysate;
(c) treating said lysate with a high salt agent comprises a mixture of 1M potassium acetate and 7M ammonium acetate at a pH between 7.0 and 9.0, thereby forming a high salt solution; and
(c) purifying said treated solution to provide isolated plasmid DNA.

### Claim 11 (depends on 10)

The process of claim 10, wherein said isolated plasmid DNA is pharmaceutical-grade plasmid DNA suitable for administration to humans.

### Claim 12 (depends on 10)

The process of claim 10, wherein at least 100 milligrams of said isolated plasmid DNA is obtained.

### Claim 13 (depends on 10)

In the process of claim 10 for isolating plasmid DNA from lysate of a cell containing said plasmid DNA, wherein the improvement comprises treating said lysate with a high salt agent capable of precipitating non-plasmid DNA cellular components contained in said lysate.

### Claim 14 (depends on 13)

The process of claim 13, wherein said high salt agent is capable of precipitating a significant portion of any RNA molecules from said cells.

### Claim 15 (depends on 13)

The process of claim 13, wherein said high salt agent comprises one or more salts at a pH above approximately 5.5.

### Claim 16 (depends on 15)

The process of claim 15, wherein said high salt agent comprises a mixture of 1M potassium acetate and 7M ammonium acetate at a pH between 7.0 and 9.0.

### Claim 17 (depends on 16)

The process of claim 16, wherein said lysate is treated with said high salt agent for at least six hours at approximately four degrees Celsius.

### Claim 18 (depends on 18)

A process for isolating plasmid DNA comprising the steps of:
(a) lysing cells containing said plasmid DNA with a lysis agent, thereby forming a lysate; and
(b) purifying said lysate with anion exchange chromatography using a step gradient, thereby producing isolated plasmid DNA (The process of claim 18, wherein the isolated plasmid DNA is enriched with at least 80% supercoiled plasmid DNA).

### Claim 19 (depends on 18)

The process of claim 18, wherein said isolated plasmid DNA is pharmaceutical-grade plasmid DNA suitable for administration to humans.

### Claim 20 (depends on 18)

The process of claim 18, wherein at least 100 milligrams of said isolated plasmid DNA is obtained.

### Claim 21 (depends on 18)

The process of claim 18, wherein said anion exchange chromatography is performed with a resin having a particle size of 20-40 microns.

### Claim 22 (depends on 22)

The process of claim 22, wherein said anion exchange chromatography has a plasmid DNA binding capacity of about 1.5 mg of plasmid per mL of resin.

### Claim 23 (depends on 18)

The process of claim 18, wherein said anion exchange chromatography is performed with a Fractogel EMD TMAE(650-S) resin.

### Claim 24 (depends on 18)

The process of claim 18 for isolating plasmid DNA from lysate of a cell containing said plasmid DNA, wherein the improvement comprises purifying said lysate with anion exchange chromatography using a step gradient, thereby producing isolated plasmid DNA enriched with at least 80% supercoiled plasmid DNA.

### Claim 25 (depends on 24)

The process of claim 24, wherein said anion exchange chromatography is performed with a resin having a particle size of 20-40 microns.

### Claim 26 (depends on 24)

The process of claim 24, wherein said anion exchange chromatography has a plasmid DNA binding capacity of about 1.5 mg of plasmid per mL of resin.

### Claim 27 (depends on 24)

The process of claim 24, wherein said anion exchange chromatography is performed with a Fractogel EMD TMAE(S) resin.

### Claim 28

A process for isolating plasmid DNA comprising the steps of:
(a) lysing cells containing said plasmid DNA with a lysis agent, thereby forming a lysate; and
(b) using hydrophobic interaction chromatography to purify said lysate, thereby providing isolated plasmid DNA.

### Claim 29 (depends on 27)

The process of claim 27, wherein said hydrophobic interaction chromatography is performed with at least 1.6M ammonium sulfate.

### Claim 30 (depends on 28)

The process of claim 28, wherein said hydrophobic interaction chromatography is performed with an Octyl Sepharose 4 FF resin.

### Claim 31 (depends on 28)

The process of claim 28, wherein said isolated plasmid DNA is pharmaceutical-grade plasmid DNA suitable for administration to humans.

### Claim 32 (depends on 28)

The process of claim 28, wherein at least 100 milligrams of said isolated plasmid DNA is obtained.

### Claim 33 (depends on 28)

The process of claim 28, wherein said plasmid DNA is not precipitated and wherein said process involves no linear gradients and uses no organic solvents.

### Claim 34 (depends on 28)

The process of claim 28, wherein said isolated plasmid DNA is substantially free of endotoxins and host cell chromosomal DNA.

### Claim 35 (depends on 28)

The process of claim 28, wherein said plasmid DNA is not exposed to acidic pH or elevated temperatures.

### Claim 36 (depends on 28)

The process of claim 28, wherein said isolated plasmid DNA is produced in a yield of at least 60%.

### Claim 37 (depends on 28)

The process of claim 28, wherein said hydrophobic interaction chromatography is performed in an aqueous solution containing a high concentration of salt.

### Claim 38 (depends on 37)

The process of claim 37, wherein said salt is ammonium sulfate.

### Claim 39 (depends on 28)

The process of claim 28, wherein said cells are recombinant E. coli cells.

### Claim 40

In a process for isolating plasmid DNA from a lysate of a cell containing said plasmid DNA, wherein the improvement comprises using hydrophobic interaction chromatography to purify said lysate, thereby providing isolated plasmid DNA.

### Claim 41 (depends on 42)

The process of claim 42, wherein said hydrophobic interaction chromatography is performed with at least 1.6M ammonium sulfate.

### Claim 42 (depends on 42)

The process of claim 42, wherein said hydrophobic interaction chromatography is performed with an Octyl Sepharose 4 FF resin.

### Claim 43 (depends on 42)

The process of claim 42, wherein said hydrophobic interaction chromatography is performed in an aqueous solution containing a high concentration of salt.

### Claim 44 (depends on 42)

The process of claim 42, wherein said salt is ammonium sulfate.

### Claim 45

A device for isolating plasmid DNA from cells containing said plasmid DNA, comprising:
(a) a means for providing fast cell resuspension in a semi-continuous mode;
(b) a means for providing mixing and cell lysis in a continuous flow mode; and
(c) a means for providing chilling and mixing to denature and precipitate chromosomal DNA, protein, and RNA.

### Claim 46 (depends on 47)

The device of claim 47, wherein said means for providing mixing and cell lysis in a continuous flow mode comprises an impeller mixer.

### Claim 47 (depends on 47)

The device of claim 47, wherein said means for providing mixing and cell lysis in a continuous flow mode comprises an in-line static mixer.

### Claim 48 (depends on 47)

The device of claim 47, wherein said means for providing mixing and cell lysis in a continuous flow mode comprises a lysis coil.

### Claim 49 (depends on 47)

The device of claim 47, further comprising a means for performing hydrophobic interaction chromatography.

### Claim 50 (depends on 47)

The device of claim 47, wherein said means for providing chilling and mixing to denature and precipitate chromosomal DNA, protein, and RNA comprises a chilled jacketed tank.

### Claim 51

A process for isolating plasmid DNA, comprising the steps of:
(1) fermenting cells containing said plasmid DNA, harvesting said cells, and washing said cells;
(2) exposing said cells to an alkaline lysis and neutralization agent, thereby forming a lysate;
(3) performing centrifugation and filtration on said lysate;
(4) treating said lysate with RNase at about 37 degrees Celsius for about one hour;
(5) filtrating said lysate and diluting said lysate with 2 volumes of WFI.
(6) passing said lysate through a Q Sepharose HP resin, a DEAE 650-S resin, and a Phenyl 650-S resin; and
(7) filtrating the eluate from step 6 to yield the final product of isolated plasmid DNA.

### Claim 52

A process for isolating plasmid DNA, comprising the steps of:
(a) fermenting cells containing said plasmid DNA, harvesting said cells, and washing said cells;
(b) exposing said cells to an alkaline lysis and neutralization agent, thereby forming a lysate;
(c) performing centrifugation or filtration on said lysate and performing a 1.5 volume dilution with WFI on said lysate;
(d) exposing said lysate to an anionic change resin;
(e) washing the nicked and/or relaxed circular plasmid, as well as residual RNA, off of the resin with about 0.6M NaCl;
(f) eluting the plasmid DNA off of the resin with about 1.9M ammonium sulfite;
(g) passing the eluate through a hydrophobic interaction chromatography resin; and
(h) filtrating the eluate to yield a final product of isolated plasmid DNA.
